Apr 252024

Top 10 Questions on the EU AI Act

William RM Long, Francesca Blythe and Lauren Cuyvers
, , ,

The EU AI Act will be the first standalone piece of legislation worldwide regulating the use and provision of AI in the EU, and will form a key consideration in AI governance programs. The AI Act will have a significant impact on many organizations inside and outside the EU, with failure to comply potentially leading to fines of up to 7% of annual worldwide turnover.

This eBook is based on the top questions asked at a recent webinar hosted by Sidley and OneTrust DataGuidance, where industry panelists covered initial reactions to the text of the EU AI Act following finalization by EU legislators and examined the key points in the AI Act that businesses need to understand.

View Article

This post is as of the posting date stated above. Sidley Austin LLP assumes no duty to update this post or post about any subsequent developments having a bearing on this post.

William RM Long

London

wlong@sidley.com

Francesca Blythe

London

fblythe@sidley.com

Lauren Cuyvers

Brussels

lcuyvers@sidley.com

You might also like
CMS Proposes Artificial Intelligence Limits and Utilization Management Guardrails for Medicare Advantage

On December 10, 2024, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule with technical changes for the Medicare Advantage (MA) Program and the Medicare Prescription Drug Benefit Program for Calendar Year 2026 (Proposed Rule). Citing the growing use of Artificial Intelligence (AI) within the healthcare sector and reports that the use of AI may lead to “algorithmic discrimination” that exacerbates inequalities within healthcare, CMS proposes, for the first time, new guardrails that must be adopted by MA plans when using AI to manage patient care. CMS also proposes several reforms addressing utilization management (UM) techniques adopted by MA plans, including requirements for such plans to conduct and report detailed analyses on the use of prior authorizations. Notably, the Proposed Rule primarily modifies MA regulations, without direct application to the Medicare Part D prescription drug program.

Post-Election Landscape: New Risks, New Opportunities

Sidley thought leaders explored risks and opportunities of a second Trump administration in a “lightning round”, covering key practice areas. Change is coming and along with it, new and fast-paced risks and opportunities.

EU AI Act: Are You Prepared for the “AI Literacy” Principle?

The EU AI Act is the world’s first horizontal and standalone law governing the commercialization and use of AI, and a landmark piece of legislation for the EU. Among the various provisions of the EU AI Act, the “AI literacy” principle is an often overlooked but key obligation which requires organizations to ensure that staff who are involved in the operation and use of AI have the necessary skills, knowledge and understanding to adequately assess AI-related risks and opportunities (e.g., through training and hiring staff with the appropriate background and skillset). This obligation – which applies from February 2, 2025 – is one of the few obligations under the EU AI Act that applies to all AI systems i.e., irrespective of the level of risk that the AI system presents. Indeed, by introducing AI literacy as one of the first provisions of the AI Act (Article 4), the EU legislators appear to underscore the significance of this requirement.